162 related articles for article (PubMed ID: 11135319)
81. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
Kleeff J; Ishiwata T; Friess H; Büchler MW; Korc M
Int J Cancer; 1998 Sep; 77(6):860-8. PubMed ID: 9714055
[TBL] [Abstract][Full Text] [Related]
82. Expression of PDGF, IGF-II, bFGF and TGF-beta 1 in pulmonary adenocarcinoma.
Takanami I; Imamuma T; Hashizume T; Kikuchi K; Yamamoto Y; Yamamoto T; Kodaira S
Pathol Res Pract; 1996 Nov; 192(11):1113-20. PubMed ID: 9122030
[TBL] [Abstract][Full Text] [Related]
83. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.
Heider TR; Lyman S; Schoonhoven R; Behrns KE
Ann Surg; 2007 Jul; 246(1):61-8. PubMed ID: 17592292
[TBL] [Abstract][Full Text] [Related]
84. The utility of SMAD4 as a diagnostic immunohistochemical marker for pancreatic adenocarcinoma, and its expression in other solid tumors.
Ali S; Cohen C; Little JV; Sequeira JH; Mosunjac MB; Siddiqui MT
Diagn Cytopathol; 2007 Oct; 35(10):644-8. PubMed ID: 17854080
[TBL] [Abstract][Full Text] [Related]
85. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH
Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665
[TBL] [Abstract][Full Text] [Related]
86. Special conference on 'growth factors, development and cancer.
Broggini M
Ann Oncol; 1994 Sep; 5(7):575-7. PubMed ID: 7993830
[No Abstract] [Full Text] [Related]
87. Role of growth factors in pancreatic cancer.
Korc M
Surg Oncol Clin N Am; 1998 Jan; 7(1):25-41. PubMed ID: 9443985
[TBL] [Abstract][Full Text] [Related]
88. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.
Korc M; Chandrasekar B; Yamanaka Y; Friess H; Buchier M; Beger HG
J Clin Invest; 1992 Oct; 90(4):1352-60. PubMed ID: 1401070
[TBL] [Abstract][Full Text] [Related]
89. New insights into pancreatic cancer stem cells.
Rao CV; Mohammed A
World J Stem Cells; 2015 Apr; 7(3):547-55. PubMed ID: 25914762
[TBL] [Abstract][Full Text] [Related]
90. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: a systematic review and meta-analysis.
Fiorino S; Chili E; Bacchi-Reggiani L; Masetti M; Deleonardi G; Grondona AG; Silvestri T; Magrini E; Zanini N; Cuppini A; Nardi R; Jovine E
Pancreatology; 2013; 13(2):147-60. PubMed ID: 23561973
[TBL] [Abstract][Full Text] [Related]
91. Genetics and biology of pancreatic ductal adenocarcinoma.
Hezel AF; Kimmelman AC; Stanger BZ; Bardeesy N; Depinho RA
Genes Dev; 2006 May; 20(10):1218-49. PubMed ID: 16702400
[TBL] [Abstract][Full Text] [Related]
92. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families.
Lynch HT; Fitzsimmons ML; Smyrk TC; Lanspa SJ; Watson P; McClellan J; Lynch JF
Am J Gastroenterol; 1990 Jan; 85(1):54-60. PubMed ID: 2296965
[TBL] [Abstract][Full Text] [Related]
93. Genomic relevance of FGF14 and associated genes on the prognosis of pancreatic cancer.
Raja A; Malik MFA; Haq F
PLoS One; 2021; 16(6):e0252344. PubMed ID: 34061869
[TBL] [Abstract][Full Text] [Related]
94. 3D Bioprinted cancer models: Revolutionizing personalized cancer therapy.
Augustine R; Kalva SN; Ahmad R; Zahid AA; Hasan S; Nayeem A; McClements L; Hasan A
Transl Oncol; 2021 Apr; 14(4):101015. PubMed ID: 33493799
[TBL] [Abstract][Full Text] [Related]
95. Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer.
Ali AI; Oliver AJ; Samiei T; Chan JD; Kershaw MH; Slaney CY
Front Oncol; 2019; 9():56. PubMed ID: 30809507
[TBL] [Abstract][Full Text] [Related]
96. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.
Khan MA; Azim S; Zubair H; Bhardwaj A; Patel GK; Khushman M; Singh S; Singh AP
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383487
[TBL] [Abstract][Full Text] [Related]
97. Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models.
Awasthi N; Scire E; Monahan S; Grojean M; Zhang E; Schwarz MA; Schwarz RE
Oncotarget; 2016 Jul; 7(30):46988-47001. PubMed ID: 27127884
[TBL] [Abstract][Full Text] [Related]
98. Inhibition of pancreatic cancer cell migration by plasma anthocyanins isolated from healthy volunteers receiving an anthocyanin-rich berry juice.
Kuntz S; Kunz C; Rudloff S
Eur J Nutr; 2017 Feb; 56(1):203-214. PubMed ID: 26476633
[TBL] [Abstract][Full Text] [Related]
99. IFN-β is a potent inhibitor of insulin and insulin like growth factor stimulated proliferation and migration in human pancreatic cancer cells.
Booy S; van Eijck CH; Janssen JA; Dogan F; van Koetsveld PM; Hofland LJ
Am J Cancer Res; 2015; 5(6):2035-46. PubMed ID: 26269762
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
